Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04005690
Title Cobimetinib or Olaparib in Treating Patients With Resectable Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute

pancreatic adenocarcinoma




Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
OHSU Knight Cancer Institute Recruiting Portland Oregon 97239 United States Details
*Shaded cells indicate that there was no data available from for the field